InvestorsHub Logo

$heff

11/23/15 9:10 AM

#91571 RE: kei #89309

CYTR 3.17..Aldoxorubicin Continues To Demonstrate
Positive Clinical Activity In Phase 2 Glioblastoma Trial.
https://t.co/zA5RQxKg5W